Sunshine Biopharma Inc. (NASDAQ:SBFM) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common Units (or Pre-Funded Units) Closed: US$6M raised · US$0.55 a unit · Warrants at US$0.66 for 60 months · Aegis Capital Corp. Dealers: Aegis Capital Corp. (lead) Use of proceeds: General corporate purposes and working capital | Oct 9, 2026 |
| Registered direct offering of shares of Common Stock and pre-funded warrants Closed: US$2.46M raised · US$2.07 a share · Aegis Capital Corp. Dealers: Aegis Capital Corp. (lead) Use of proceeds: General corporate purposes and working capital | Apr 3, 2025 |